Allianz Asset Management Gmb H Abb Vie Inc. Call Options Transaction History

Allianz Asset Management Gmb H

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $2.54 Million - $3.09 Million	15,500 Added 27.73%	71,400 $14.1 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $7.89 Million - $9.22 Million	51,000 Added 1040.82%	55,900 $9.59 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $783,118 - $892,290	4,900 New	4,900 $892,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.